Staidson BioPharm(SZ:300204) Xin Lang Cai Jing·2025-08-28 02:03Core Viewpoint - Shuyou Shen (Beijing) Biopharmaceutical Co., Ltd. experienced a decline of 5.36% in stock price, closing at 50.16 CNY per share, with a trading volume of 383 million CNY and a turnover rate of 1.65%, resulting in a total market capitalization of 23.965 billion CNY [1] Company Overview - Shuyou Shen was established on August 16, 2002, and went public on April 15, 2011. The company is primarily engaged in the research, development, production, and sales of biological products and certain chemical drugs [1] Fund Holdings - Huafu Fund has a significant position in Shuyou Shen, with its Huafu Health and Entertainment Flexible Allocation Mixed A Fund (001563) holding 190,000 shares, accounting for 9.57% of the fund's net value, making it the largest holding [2] - The fund has reported a floating loss of approximately 539,600 CNY as of the latest update [2] - The Huafu Health and Entertainment Flexible Allocation Mixed A Fund was established on August 4, 2015, with a current scale of 33.8496 million CNY. Year-to-date returns stand at 65.79%, ranking 165 out of 8,190 in its category, while the one-year return is 69.07%, ranking 1,083 out of 7,966 [2] - The fund manager, Liao Qingyang, has been in charge for 3 years and 293 days, with total assets under management of 74.027 million CNY. The best return during his tenure is 44.88%, while the worst is -0.03% [2]